Can anticoagulants slow or prevent the progression of thromboangiitis obliterans (Buerger’s disease), and how do they influence treatment outcomes in patients with this rare vascular condition?
Home/Vascular Condition
Sign Up to our social questions and Answers Engine to ask questions, answer people’s questions, and connect with other people.
Please briefly explain why you feel this question should be reported.
Please briefly explain why you feel this answer should be reported.
Please briefly explain why you feel this user should be reported.